Aspen Pharmacare Holdings Ltd
JSE:APN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
|
Eurofins Scientific SE
OTC:ERFSF
|
LU |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
Taboola.com Ltd
F:1FY
|
US |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
M
|
Molinos Agro SA
BCBA:MOLA
|
AR |
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
OTC:AIQUY
|
FR |
|
T
|
Truscreen Group Ltd
ASX:TRU
|
NZ |
|
Regal Rexnord Corp
NYSE:RRX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APN's stock price target?
Not Available
APN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 4%.